The GLP is committed to full transparency. Download and review our 2019 Annual Report

x

Promising immunotherapy drug to treat peanut allergies may be approved although 10% of study subjects had serious side effects

On [September 13], a panel of experts assembled by the Food and Drug Administration voted that the agency should approve a drug ...